---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-058049"
form_type: "8-K"
ticker: "ALBT"
cik: "0001630212"
company_name: "Avalon GloboCare Corp."
filed_at: "2025-06-26T23:59:59+00:00"
generated_at: "2026-05-18T17:54:58.244194+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avalon GloboCare and Qi Diagnostics agree to co-develop cannabis breathalyzer for impaired driving detection

## Summary
- Definitive agreement for co-development of VOC nanosensor-based point-of-care cannabis breathalyzer.
- Total milestone payments up to $975,000 across four stages: data collection, prototype design, production, human testing.
- Qi Diagnostics retains IP; Q&A (Avalon sub) earns up to 50% passive financial interest in IP upon all milestones.
- Device aims to support real-time detection of cannabis-impaired driving for law enforcement and workplace safety.

## SEC filing metadata
- accession: 0001213900-25-058049
- form_type: 8-K
- ticker: ALBT
- cik: 0001630212
- company_name: Avalon GloboCare Corp.
- filed_at: 2025-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630212/000121390025058049/0001213900-25-058049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630212/000121390025058049/ea0246882-8k_avalon.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-058049
- JSON: https://secwatch.observer/filing/0001213900-25-058049.json
- Plain text: https://secwatch.observer/filing/0001213900-25-058049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.